Qi Chao
Shanghai Zhangjiang Laboratory(CN)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Synthesis and biological activity, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)(2009)638 cited
- → Identification of N-(5-tert-Butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Dihydrochloride (AC220), a Uniquely Potent, Selective, and Efficacious FMS-Like Tyrosine Kinase-3 (FLT3) Inhibitor(2009)191 cited
- → Substituted Isoquinolines and Quinazolines as Potential Antiinflammatory Agents. Synthesis and Biological Evaluation of Inhibitors of Tumor Necrosis Factor α(1999)161 cited
- → Identification of 1-(3-(6,7-Dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea Hydrochloride (CEP-32496), a Highly Potent and Orally Efficacious Inhibitor of V-RAF Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) V600E(2011)58 cited
- → Structure-Guided Design of Group I Selective p21-Activated Kinase Inhibitors(2015)39 cited
- → Arylcarboxyamino-substituted diaryl ureas as potent and selective FLT3 inhibitors(2009)31 cited
- → Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability(2017)28 cited
- → Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors(2015)26 cited
- → Concise and stereospecific synthesis of novel bicyclic dideoxynucleosides as potential antiviral agents(1998)23 cited
- → Synthesis of bicarbocyclic dideoxynucleosides as potential antiviral agents(1997)19 cited